Clarivate Life Sciences & Healthcare Rebrands as Independent Company 'Insira'
Clarivate has spun off its Life Sciences & Healthcare division, which has launched as a fully independent company under the new name Insira.
Stocks · News reference
Clarivate Addresses Critical PHP Vulnerabilities CVE-2026-109618 And CVE-2026-109619; No Customer Impact Reported
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Cognizant (CTSH) Beats Q3 Earnings and Revenue Estimates
Cognizant reported Q3 2026 earnings of $1.49 per share, beating consensus estimates of $1.46, with revenues of $5.66 billion slightly exceeding expectations. However, the stock has declined 20.1% year-to-date compared to the S&P 500's 13.1% gain. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.
Clarivate Announces Adoption Milestone for Web of Science Research Intelligence
Clarivate reported that over 100 institutions across 25 countries have adopted its AI-native Web of Science Research Intelligence platform since its launch in May 2026.